Skip to main content
SpringerLink
Log in

Is Hawthorne bothering pharmaceutical care research?

  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weinberger M, Murray MD, Marrero DG et al. Effectiveness of pharmacist care for patients with reactive airways disease. JAMA 2002; 288: 1594–602.

    Google Scholar 

  2. Young D. Results of pharmaceutical care program disappoints researchers. Am J Health Syst Pharm 2002; 288 1642–3.

    Google Scholar 

  3. Schulz M, Verheyen F, Mühlig S et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol 2001; 41: 668–76.

    Google Scholar 

  4. Herborg H, Søndergaard B, Frøkjaer B et al. Improving drug therapy for patients with asthma - part 1: patient outcomes. J Am Pharm Assoc (Wash) 2001; 41 (4): 539–50.

    Google Scholar 

  5. Campbell MK, Mollison J, Steen N et al. Analysis of cluster randomized trials in primary care: a practice approach. Fam Practice 2000; 17: 192–6.

    Google Scholar 

Download references

Authors
  1. Foppe Van Mil
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Mil, F. Is Hawthorne bothering pharmaceutical care research?. Pharm World Sci 25, 37 (2003). https://doi.org/10.1023/A:1023239725705

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023239725705

Keywords

Search

Navigation